Generation Park

BMS to Build $2.3B Houston Campus; Lilly Expands

Bristol Myers Squibb is investing about $2.3 billion to build a 600,000-square-foot modular, multi-modal manufacturing campus at Generation Park in Houston, part of its $40 billion five-year U.S. investment plan, to produce small molecules, biologics, and antibody-drug conjugates while enabling future expansion. The project will create roughly 500 permanent jobs and about 2,000 construction roles through 2030, supported by Texas incentives, as drugmakers continue expanding domestic manufacturing under government pressure to boost U.S. production.